# Bevacizumab and Long Acting Gas in Diabetic Vitrectomy

> **NCT00656435** · PHASE3 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00656435
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-08
- **Final completion:** 2008-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2008-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656435, "Bevacizumab and Long Acting Gas in Diabetic Vitrectomy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00656435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*